Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor

Journal of Thoracic Oncology

Volumn 10, Issue 9, 2015, Pages 1301-1310

  Kadota, Kyuichi ^a,b   Nitadori, Jun Ichi ^a,c   Ujiie, Hideki ^a   Buitrago, Daniel H ^a   Woo, Kaitlin M ^a   Sima, Camelia S ^a   Travis, William D ^a   Jones, David R ^a   Adusumilli, Prasad S ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Immune response; Non small cell lung cancer; Survival; Tumor infiltrating lymphocytes

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHLORDANE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG RESECTION; LYMPH FOLLICLE; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL LUNG CARCINOMA; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; VALIDATION STUDY; IMMUNOLOGY; LUNG TUMOR; METABOLISM; NEUTROPHIL; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MICROENVIRONMENT;

EID: 84940106179     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000617     Document Type: Article

References (54)

1. Siegel R, Naishadham D, Jemal A, Cancer statistics, 2012. CA Cancer J Clin 2012 62 10 29
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, Global cancer statistics. CA Cancer J Clin 2011 61 69 90
3. Youlden DR, Cramb SM, Baade PD, The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol 2008 3 819 831
4. Devesa SS, Bray F, Vizcaino AP, Parkin DM, International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005 117 294 299
5. Goldstraw P, Crowley J, Chansky K, International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007 2 706 714
6. Galon J, Costes A, Sanchez-Cabo F, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 313 1960 1964
7. Pagès F, Berger A, Camus M, Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005 353 2654 2666
8. Zhang L, Conejo-Garcia JR, Katsaros D, Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003 348 203 213
9. Pagès F, Kirilovsky A, Mlecnik B, In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009 27 5944 5951
10. Mahmoud SM, Paish EC, Powe DG, Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011 29 1949 1955
11. Ujiie H, Kadota K, Nitadori J, Tumoral and stromal immune microenvironment in epithelioid malignant pleural mesothelioma: tumoral IL-7 receptor, tumor-infiltrating CD20+ lymphocytes and their ratio to tumor-associated macrophages are independent predictors of survival. Oncoimmunology 2015. April 1;4:e1009285.
12. Suzuki K, Kachala SS, Kadota K, Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res 2011 17 5247 5256
13. Wakabayashi O, Yamazaki K, Oizumi S, CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 2003 94 1003 1009
14. Trojan A, Urosevic M, Dummer R, Giger R, Weder W, Stahel RA, Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer. Lung Cancer 2004 44 143 147
15. Hiraoka K, Miyamoto M, Cho Y, Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 2006 94 275 280
16. Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT, Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008 14 5220 5227
17. Petersen RP, Campa MJ, Sperlazza J, Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 2006 107 2866 2872
18. Lee MC, Buitrago DH, Kadota K, The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer. Oncoimmunology 2014 3 e967142
19. Suzuki K, Kadota K, Sima CS, Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol 2013 31 490 498
20. Edge SB, Byrd DR, Compton CC, American Joint Committee on Cancer Cancer Staging Manual 2009 7th Ed New York Springer 253 270
21. Azab B, Bhatt VR, Phookan J, Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol 2012 19 217 224
22. Gondo T, Nakashima J, Ohno Y, Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 2012 79 1085 1091
23. Jankova L, Dent OF, Chan C, Chapuis P, Clarke SJ, Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer. BMC Cancer 2013 13 442
24. Mano Y, Shirabe K, Yamashita Y, Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 2013 258 301 305
25. Pichler M, Hutterer GC, Stoeckigt C, Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013 108 901 907
26. Szkandera J, Stotz M, Eisner F, External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients. PLoS One 2013 8 e78225
27. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E, Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009 137 425 428
28. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T, Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res 2011 31 2995 2998
29. Yao Y, Yuan D, Liu H, Gu X, Song Y, Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother 2013 62 471 479
30. Suzuki K, Kadota K, Sima CS, Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. Cancer Immunol Immunother 2011 60 1721 1728
31. + myeloid cells in association with tumor budding at the invasion front of colorectal cancer. Cancer Sci 2011 102 1724 1733
32. Kadota K, Villena-Vargas J, Nitadori J, Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma. Ann Surg Oncol. 2015 Jan 22. [Epub ahead of print].
33. Yoshizawa A, Fukuoka J, Shimizu S, Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res 2010 16 240 248
34. Mazumdar M, Glassman JR, Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med 2000 19 113 132
35. Chappell R, Competing risk analyses: how are they different and why should you care? Clin Cancer Res 2012 18 2127 2129
36. Dignam JJ, Zhang Q, Kocherginsky M, The use and interpretation of competing risks regression models. Clin Cancer Res 2012 18 2301 2308
37. Gray RJ, A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988 16 1141 1154
38. Paesmans M, Sculier JP, Libert P, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 1995 13 1221 1230
39. Teramukai S, Kitano T, Kishida Y, Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 2009 45 1950 1958
40. Horne ZD, Jack R, Gray ZT, Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res 2011 171 1 5
41. Shojaei F, Singh M, Thompson JD, Ferrara N, Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA 2008 105 2640 2645
42. Nozawa H, Chiu C, Hanahan D, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 2006 103 12493 12498
43. Wu QD, Wang JH, Condron C, Bouchier-Hayes D, Redmond HP, Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 2001 280 C814 C822
44. Hicks AM, Riedlinger G, Willingham MC, Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci USA 2006 103 7753 7758
45. Fridlender ZG, Sun J, Kim S, Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009 16 183 194
46. Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S, Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 2010 120 1151 1164
47. Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 2014 124 5466 5480
48. Mishalian I, Bayuh R, Levy L, Zolotarov L, Michaeli J, Fridlender ZG, Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol Immunother 2013 62 1745 1756
49. Ilie M, Hofman V, Ortholan C, Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 2012 118 1726 1737
50. Jensen TO, Schmidt H, Møller HJ, Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 2012 118 2476 2485
51. Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H, Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 2009 27 4709 4717
52. Trellakis S, Bruderek K, Dumitru CA, Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 2011 129 2183 2193
53. Kondratieva TK, Rubakova EI, Linge IA, Evstifeev VV, Majorov KB, Apt AS, B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective Bacillus Calmette-Guérin vaccination against tuberculosis infection in mice. J Immunol 2010 184 1227 1234
54. Smelt SC, Cotterell SE, Engwerda CR, Kaye PM, B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol 2000 164 3681 3688